{"transactions":[{"id":738811,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38438,"kind":"person","name":"Levine Wendy Lauren","position":1,"cik":"0001881038","reported_name":"Levine Wendy Lauren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2026-06-16T00:07:56.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":4.65,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-028781","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226028781/ownership.xml","form_type":"4"}},{"id":1144243,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38438,"kind":"person","name":"Levine Wendy Lauren","position":1,"cik":"0001881038","reported_name":"Levine Wendy Lauren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2025-05-19T20:31:03.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant."}],"balance_after":64000,"derivative":{"exercise_price":1.48,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001641172-25-011476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000164117225011476/ownership.xml","form_type":"4"}},{"id":1301133,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38438,"kind":"person","name":"Levine Wendy Lauren","position":1,"cik":"0001881038","reported_name":"Levine Wendy Lauren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2025-01-17T21:07:02.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":1.42,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-25-002765","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315225002765/ownership.xml","form_type":"4"}},{"id":1436451,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38438,"kind":"person","name":"Levine Wendy Lauren","position":1,"cik":"0001881038","reported_name":"Levine Wendy Lauren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2024-08-12T20:50:39.000Z","date":"2024-08-08","kind":"grant","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant."}],"balance_after":17000,"derivative":{"exercise_price":1.02,"exercise_date":"2024-08-08","expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001493152-24-031317","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315224031317/ownership.xml","form_type":"4"}},{"id":1807974,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38438,"kind":"person","name":"Levine Wendy Lauren","position":1,"cik":"0001881038","reported_name":"Levine Wendy Lauren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2023-08-15T16:27:41.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant."}],"balance_after":17000,"derivative":{"exercise_price":4.25,"exercise_date":"2023-08-10","expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001493152-23-028918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315223028918/ownership.xml","form_type":"4"}},{"id":2183106,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38438,"kind":"person","name":"Levine Wendy Lauren","position":1,"cik":"0001881038","reported_name":"Levine Wendy Lauren","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Option to Buy)","published_at":"2022-08-17T19:34:30.000Z","date":"2022-08-11","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant."}],"balance_after":17000,"derivative":{"exercise_price":10.28,"exercise_date":"2023-08-11","expiration_date":"2032-08-11","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000719135-22-000071","document":"wf-form4_166076485754314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913522000071/wf-form4_166076485754314.xml","form_type":"4"}}]}